Adenovirus and marrow transplantation in children

Pediatric Pathology and Molecular Medicine

Volumn 19, Issue 2-3, 2000, Pages 97-114

  Foster, C B ^a   Eun Hwa Choi, ^a   Chanock, S J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Immunocompromised host; Serotype; Supportive care; Viral infection

Indexed keywords

IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; RIBAVIRIN;

ADENOVIRUS; ARTICLE; BONE MARROW TRANSPLANTATION; CHILDHOOD DISEASE; GASTROENTERITIS; HEMORRHAGIC CYSTITIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; NEPHRITIS; PANCREATITIS; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS ENCEPHALITIS; VIRUS HEPATITIS; VIRUS INFECTION; VIRUS PNEUMONIA;

EID: 0033802524     PISSN: 15227952     EISSN: None     Source Type: Journal    
DOI: 10.1080/15513810009168627     Document Type: Article

References (99)

1. Adenoviral infections in children
2. New perspectives in adenoviruses
3. Adenovirus
4. Adenoviruses
5. Adenoviruses in the immunocompromised host
6. Increasing incidence of adenovirus disease in bone marrow transplant recipients
7. Adenovirus infection after pediatric bone marrow transplantation
8. Evolving pathogens in allogeneic bone marrow transplantation: Increased fatal adenoviral infections
9. Adenovirus infections in patients undergoing bone-marrow transplantation
10. Two new candidate adenovirus serotypes
11. Adenoviridae: The viruses and their Replication
12. Adenoviruses: Group name proposed for new respiratory-tract viruses
13. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
14. The molecular basis of adenovirus pathogenesis
15. Adenovirus - An eternal archetype
16. Molecular mechanisms by which adenoviruses counteract antiviral immune defenses
17. Induction of suceptibility to tumor necrosis factor by E1A is dependent on binding to either p300 or p105-Rb and induction of DNA synthesis
18. Evaluation of four methods for rapid detection of adenovirus
19. Comparison of three techniques for detection of respiratory viruses in nasopharyngeal aspirates from children with lower acute respiratory infections
20. Correlation of viral infection, histology, and mortality in immunocompromised patients with pneumonia. Analysis by in situ hybridization and the polymerase chain reaction
21. Adenovirus pulmonary infections identified by PCR and in situ hybridization in bone marrow transplant recipients
22. Rapid detection of enteric adenoviruses by means of the polymerase chain reaction
23. Control of adenovirus acute respiratory disease in U.S. army trainees
24. Immunization with live type 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7
25. Viral upper respiratory infections
26. 'Childhood' viruses as a cause of pneumonia in adults
27. Disseminated adenoviral infection presenting as acute pancreatitis
28. Fatal adenovirus meningoencephalitis in a bone marrow transplant patient
29. Adenovirus-related hemophagocytic syndrome after bone marrow transplantation
30. Late fatal adenovirus pneumonitis in a lung transplant recipient
31. Adenovirus infection in adult orthotopic liver transplant recipients: Incidence and clinical significance
32. Severe diffuse adenovirus 7a pneumonia in a child with combined immunodeficiency: Possible therapeutic effect of human immune serum globulin containing specific neutralizing antibody
33. Fatal disseminated adenovirus 11 pneumonia in an agammaglobulinemic patient
34. Fatal hepatic and bronchial necrosis in adenovirus infection with thymic alymphoplasia
35. Pathology of the pancreas in severe combined immunodeficiency and DiGeorge syndrome: Acute graft-versus-host disease and unusual viral infections
36. Pathology of the liver in severe combined immunodeficiency and DiGeorge syndrome
37. Isolation of adenovirus type 11 from the brain of a neonate with pneumonia and encephalitis
38. Adenovirus complement-fixing antibody titers from birth through the first year of life: A longitudinal study
39. Disseminated adenovirus infection with hepatic necrosis in patients with human immunodeficiency virus infection and other immunodeficiency states
40. Fatal adenovirus disease and human immunodeficiency virus infection
41. Adenovirus (AV) viremia in HIV-infected children
42. Adenovirus infection
43. Genomic variation of adenovirus type 5 isolates recovered from bone marrow transplant recipients
44. Nosocomial and endemic infections with a genome type of adenovirus type 5
45. Nosocomial viral pneumonia in the intensive care unit
46. Selected nosocomial viral infections
47. Fatal disseminated adenovirus type 2 infection following bone marrow transplantation for Hurler's syndrome: A primary infection
48. Adenovirus infection in pediatric liver transplant recipients
49. Serological studies of adenoviral hepatitis following pediatric liver transplantation
50. High incidence of adeno- and polyomavirus-induced hemorrhagic cystitis in bone marrow allotransplantation for hematological malignancy following T cell depletion and cyclosporine
51. Role of adenovirus type 11 in hemorrhagic cystitis secondary to immunosuppression
52. Hemorrhagic cystitis due to adenovirus type 11 after allogeneic bone marrow transplantation in two patients with aplastic anemia
53. Late-onset hemorrhagic cystitis after hematopoietic stem cell transplantation in children
54. Molecular epidemiology of adenovirus type 35 infections in immunocompromised hosts
55. Adenovirus infections in adult bone marrow transplant (BMT) recipients
56. Viral infections in pediatric bone marrow transplant patients
57. Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation
58. Fulminant adenovirus hepatitis after allogeneic bone marrow transplantation
59. Adenovirus hepatitis in an immunosuppressed adult patient
60. Fatal adenovirus 32 infection in a bone marrow transplant recipient
61. Fulminant hepatic necrosis caused by adenovirus type 5 following bone marrow transplantation
62. Fulminant liver failure induced by adenovirus after bone marrow transplantation
63. Disseminated adenovirus serotype 31 infection in an immunocompromised host
64. Respiratory virus infection in immunocompromised patients
65. Viral pneumonia in the immunocompromised adult with neoplastic disease: The role of common community respiratory viruses
66. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients
67. Dual infection with Pneumocystis carinii and respiratory viruses complicating bone marrow transplantation
68. Recovery of viruses other than cytomegalovirus from bronchoalveolar lavage fluid
69. Fiberoptic bronchoscopy for diagnosis of opportunistic pulmonary infections after bone marrow transplantation
70. Infectious gastroenteritis in bonemarrow-transplant recipients
71. Etiology and outcome of diarrhea after marrow transplantation: A prospective study
72. Virus recovery from stools of patients undergoing bone marrow transplantation
73. Pneumatosis intestinalis in children after allogeneic bone marrow transplantation
74. Diffuse intestinal ulceration after marrow transplantation: A clinicopathologic study of 13 patients
75. Adenoviral nephritis: A newly described clinical-pathological entity in bone marrow transplantation
76. Necrotizing tubulointerstitial nephritis associated with adenovirus infection
77. Acute renal failure and degenerative tubular lesions associated with in situ formation of adenovirus immune complexes in a patient with allogeneic bone marrow transplantation
78. Hemorrhagic cystitis after bone marrow transplantation. Risk factors and complications
79. Preparative regimens for marrow transplantation containing busulphan are associated with haemorrhagic cystitis and hepatic veno-occlusive disease but a short duration of leucopenia and little oro-pharyngeal mucositis
80. Hemorrhagic cystitis following high-dose chemotherapy and bone marrow transplantation in children with malignancies: Incidence, clinical course, and outcome
81. Hemorrhagic cystitis associated with adenovirus infection in bone marrow transplantation
82. Adenovirus-induced late onset hemorrhagic cystitis following allogeneic bone marrow transplantation
83. Haemorrhagic cystitis in bone marrow transplantation patients: Possible increased risk associated with prior busulphan therapy
84. Haemorrhagic cystitis in paediatric bone marrow transplant patients: An association with infective agents, GVHD and prior cyclophosphamide
85. Hemorrhagic cystitis associated with allogeneic and autologous bone marrow transplantation for malignant neoplasms in adults
86. Cytomegalovirus-induced hemorrhagic cystitis following bone marrow transplantation
87. Association of BK viruria with hemorrhagic cystitis in recipients of bone marrow transplants
88. Monitoring of polyomavirus BK viruria in bone marrow transplantation patients by DNA hybridization assay and by polymerase chain reaction: An approach to assess the relationship between BK viruria and hemorrhagic cystitis
89. Human polyomavirus: Lack of relationship of viruria to prolonged or severe hemorrhagic cystitis after bone marrow transplant
90. Aplastic anaemic, bone-marrow transplantation, and polyoma and other virus infections
91. Hemorrhagic cystitis due to adenovirus infection following bone marrow transplantation
92. Hemorrhagic cystitis associated with urinary excretion of adenovirus type 11 following allogeneic bone marrow transplantation
93. Ureteric obstruction after allogeneic bone marrow transplantation: An unusual complication
94. Intravenous ribavirin therapy for adenovirus cystitis after allogeneic bone marrow transplantation
95. Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin
96. Intravenous ribavirin therapy for disseminated adenovirus infection
97. Adenovirus-associated hemorrhagic cystitis treated with intraveneous ribavirin
98. Adenovirus pneumonitis successfully treated with intravenous ribavirin
99. Mining variations in genes of innate and phagocytic immunity: Current status and future prospects